Black Diamond Therapeutics reported total assets of $125.03M and total liabilities of $28.94M for the quarter ended Jun 2026, down 24.9% year over year. This balance sheet covers 31 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 46.60M | 65.80M | 54.08M | 55.88M | 53.96M | 34.31M | 39.14M | 41.89M | 57.98M | 56.22M | 25.42M | 32.81M | 23.43M | 36.44M | 98.42M | 29.99M | 30.86M | 20.99M | 30.07M | 19.19M | |||||||||||
| Short-term InvestmentsInvestments (Current) | 188.41M | 143.99M | 125.66M | 105.01M | 90.22M | 88.49M | 64.22M | 47.64M | 86.28M | 75.18M | 89.78M | 90.16M | 89.26M | 62.14M | 53.98M | 112.84M | 104.64M | 107.66M | 88.19M | 91.31M | |||||||||||
| Cash & Current Investments | 235.01M | 209.79M | 179.74M | 160.89M | 144.18M | 122.81M | 103.37M | 89.53M | 144.26M | 131.40M | 115.20M | 122.97M | 112.68M | 98.58M | 152.40M | 142.83M | 135.50M | 128.65M | 118.26M | 110.51M | |||||||||||
| Prepaid Assets | 6.54M | 5.92M | 8.56M | 7.67M | 6.80M | 4.90M | 4.61M | 3.46M | 2.79M | 2.63M | 3.61M | 3.78M | 2.86M | 2.60M | 3.28M | 3.90M | 3.49M | 3.79M | 4.71M | 4.89M | |||||||||||
| Current Assets | 241.55M | 215.70M | 188.30M | 168.56M | 150.98M | 127.71M | 107.98M | 92.99M | 147.05M | 134.03M | 118.81M | 126.75M | 115.54M | 101.18M | 155.68M | 146.73M | 138.99M | 132.44M | 122.97M | 115.39M | |||||||||||
| Non-Current Assets | |||||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 2.89M | 3.04M | 2.81M | 2.87M | 2.73M | 2.59M | 2.33M | 2.25M | 1.82M | 1.73M | 1.64M | 1.56M | 1.47M | 1.39M | 1.30M | 1.21M | 1.13M | 0.36M | 0.34M | 0.31M | |||||||||||
| Long-Term Investments | |||||||||||||||||||||||||||||||
| Other Non-Current Assets | 1.22M | 1.22M | 1.22M | 1.17M | 1.17M | 1.17M | 1.17M | 1.23M | 0.82M | 0.82M | 0.82M | 0.82M | 0.83M | 0.82M | 0.82M | 0.82M | 0.83M | 0.83M | 0.83M | 0.83M | |||||||||||
| Non-Current Assets | 32.58M | 31.98M | 31.18M | 30.28M | 29.44M | 28.55M | 27.61M | 26.89M | 25.33M | 24.53M | 23.71M | 23.23M | 22.36M | 21.46M | 20.57M | 19.66M | 18.74M | 10.57M | 9.96M | 9.63M | |||||||||||
| Assets | 274.13M | 247.68M | 219.48M | 198.83M | 180.42M | 156.25M | 135.58M | 119.88M | 172.38M | 158.57M | 142.52M | 149.99M | 137.90M | 122.64M | 176.25M | 166.38M | 157.73M | 143.01M | 132.92M | 125.03M | |||||||||||
| Liabilities | |||||||||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||||||||
| Accounts Payables | 4.86M | 4.11M | 1.88M | 2.22M | 5.76M | 1.88M | 3.05M | 2.74M | 0.69M | 2.32M | 1.18M | 0.76M | 1.97M | 4.01M | 2.63M | 0.77M | 0.97M | 0.58M | 2.97M | 1.40M | |||||||||||
| Notes Payables | |||||||||||||||||||||||||||||||
| Payables | 4.86M | 4.11M | 1.88M | 2.22M | 5.76M | 1.88M | 3.05M | 2.74M | 0.69M | 2.32M | 1.18M | 0.76M | 1.97M | 4.01M | 2.63M | 0.77M | 0.97M | 0.58M | 2.97M | 1.40M | |||||||||||
| Accumulated Expenses | 21.50M | 19.54M | 17.59M | 17.48M | 15.38M | 13.38M | 9.80M | 11.16M | 14.37M | 17.32M | 15.68M | 17.68M | 18.83M | 16.57M | 14.22M | 16.03M | 14.57M | 15.15M | 11.56M | 14.44M | |||||||||||
| Total Current Liabilities | 26.36M | 23.64M | 19.47M | 19.71M | 21.14M | 15.26M | 12.85M | 13.90M | 15.07M | 19.65M | 16.85M | 18.44M | 20.80M | 20.57M | 16.85M | 16.80M | 15.54M | 15.73M | 14.53M | 15.84M | |||||||||||
| Non-Current Liabilities | |||||||||||||||||||||||||||||||
| Preferred Stock Liabilities | |||||||||||||||||||||||||||||||
| Operating Leases | 29.68M | 28.14M | 28.25M | 28.85M | 28.82M | 25.30M | 27.45M | 26.76M | 26.04M | 22.18M | 24.55M | 23.78M | 23.00M | 18.78M | 17.88M | 16.97M | 16.04M | 15.07M | 14.09M | 13.10M | |||||||||||
| Other Non-Current Liabilities | |||||||||||||||||||||||||||||||
| Total Non-Current Liabilities | |||||||||||||||||||||||||||||||
| Total Liabilities | 55.18M | 51.78M | 46.92M | 46.46M | 47.19M | 40.56M | 37.39M | 37.68M | 38.06M | 41.83M | 38.22M | 38.97M | 40.47M | 39.35M | 34.73M | 33.77M | 31.58M | 30.80M | 28.62M | 28.94M | |||||||||||
| Shareholder's Equity | |||||||||||||||||||||||||||||||
| Total Debt | |||||||||||||||||||||||||||||||
| Common Equity | 218.95M | 195.90M | 172.56M | 152.37M | 133.23M | 115.69M | 98.19M | 82.20M | 134.32M | 116.74M | 104.31M | 110.52M | 97.43M | 83.28M | 141.52M | 132.61M | 126.15M | 112.21M | 104.30M | 96.09M | |||||||||||
| Liabilities and Shareholders Equity | 274.13M | 247.68M | 219.48M | 198.83M | 180.42M | 156.25M | 135.58M | 119.88M | 172.38M | 158.57M | 142.52M | 149.99M | 137.90M | 122.64M | 176.25M | 166.38M | 157.73M | 143.01M | 132.92M | 125.03M | |||||||||||
| Retained Earnings | 436.75M | 440.13M | 443.66M | 446.91M | 449.62M | 452.50M | 455.23M | 457.87M | 532.70M | 534.19M | 540.05M | 566.69M | 568.43M | 570.36M | 572.09M | 573.75M | 575.63M | 576.84M | 578.10M | 579.83M | |||||||||||
| Treasury Shares |